BioNTech SE (BNTX) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 4.2% on average (either way), rising 3 times and falling 9. EPS beat estimates 7 of 12 times; revenue 6 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | 0.83 | 0.76 | +9.2% | 1.46B | 1.17B | +3.6% |
| Q2 FY2026 | 2026-08-04 | -3.70 | -2.40 | -54.3% | 120.6M | 180.2M | -0.1% |
| Q1 FY2026 | 2026-05-05 | -2.43 | -2.54 | +4.4% | 136.4M | 207.4M | -4.1% |
| Q4 FY2025 | 2026-03-10 | -1.44 | -0.22 | -556.7% | 1.07B | 902.3M | -11.1% |
| Q3 FY2025 | 2025-11-03 | -0.14 | -1.12 | +87.5% | 1.78B | 843.7M | +0.9% |
| Q2 FY2025 | 2025-08-04 | -1.82 | -2.69 | +32.3% | 307.1M | 177.8M | +3.5% |
| Q1 FY2025 | 2025-05-05 | -1.82 | -2.48 | +26.5% | 200.4M | 215.1M | -9.7% |
| Q4 FY2024 | 2025-03-10 | 1.15 | 0.46 | +148.7% | 1.23B | 1.18B | -9.6% |